INTRODUCTION
Sera of various animal species have been reported to contain substances active against polioviruses (1) . Although many workers were of the opinion that poliovirus-reactive substances are mostly immunoglobulin M (IgM) of the serum (2-5), we demonstrated by radioimmunoelectrophoretic and other methods that they are heterogeneous with respect to the immunoglobulin class: the active substances in equine sera were identified as one of the three immunoglobulins, IgM, slowly migrating IgG and IgG (T) previously referred to as IgA (T) (6) , while those in bovine sera were found to be either IgM or IgG globulin (7, 8) . From these results, we henceforth use the term poliovirus-reactive immunoglobulins (PRIgs) for these active substances. Previously, by propagating poliovirus type 1(Mahoney strain) in cell cultures in the presence of poliovirus-reactive (or PRIg-containing) equine sera, we obtained a number of virus mutants (PRIg-resistant mutants) no more neutralizable with the same PRIgs used for their selection (9) . Crossneutralization tests between these resistant mutants and a number of poliovirusreactive equine sera distinguished five groups of sera each containing PRIg with a different specificity, i.e., HN31, HN11, 1133, 11577 and 11520 (9) . Further, antibody-adsorption tests with the five different PRIg-resistant poliovirus mutants revealed that the antiserum against Mahoney strain contained five different monospecific neutralizing antibodies (HN31, HN11, 1133, HS77 and 11520 antibodies) corresponding in specificity to the five different PRIg mentioned above (9) .
In the present article, we report the detection of two new PRIgs) in bovine serum and the mode of actions of PRIgs with different specificities and compare the activity of various PRIgs in the neutralization and precipitation reactions with that of various monospecific antibodies isolated from rabbit immune serum by the use of PRIg-resistant mutants.
MATERIALS AND METHODS
Cell cultures and media: A stable line of monkey kidney (MS) cells and HeLa cells used in this study were propagated in Eagle's minimum essential medium (MEM) supplemented with 5% calf serum and 0.058% glutamine. Phosphatebuffered saline (PBS, pH7.3) was used for virus and serum dilution.
Virus: Mahoney strain of type 1 poliovirus and its PRIg-resistant mutants were employed.
All viruses were purified by three successive plaque isolation before preparation of stocks. The stock viruses were prepared by infecting MS cells in Eagle's MEM without animal serum. The immunizing antigen of Mahoney strain was grown in HeLa cells with serum-free Eagle's MEM.
Plaque assay: Duplicate MS cell monolayer prepared in 70-mm petri dishes were washed once with PBS, inoculated with 0.4 ml per dish of virus, overlaid after 1 hr incubation at room temperature with 8 ml of Eagle's MEM containing 1.1% Bacto-agar, glutamine and antibiotics (first overlay medium), and then incubated at 37 C in a humidified atmosphere of 5% CO2 and air. Two days later, 4 ml of a second overlay medium containing 0.01% neutral red was added and plaques were counted after an additional incubation for 6 to 8 hr.
Plaque neutralization test: The plaque neutralization test was carried out on MS cell monolayers by inoculating 100 plaque-forming units (PFU)/0 .2 ml of virus mixed with an equal volume of serial twofold dilutions of serum as described previously (8) .
Plaque reduction test:
The effect of PRIgs incorporated in the overlay medium on the development of plaques was evaluated in the plaque reduction test . After adsorption of virus (100 PFU) at room temperature for 1 hr , MS cell monolayers were overlaid with 8 ml of the first overlay medium containing 10% of either poliovirus-reactive equine or bovine serum . The plaques were measured and counted usually after 3 day's incubation . Reduction in plaque diameter (PRd) or plaque number (PRn) was calculated by the following equation (8): 
RESULTS

Screening o f Equine and Bovine Sera by Virus Neutralization and Precipitation Reactions and Mode o f Action o f Representative
Poliovirus-reactive Animal Sera with Different Speci ficities
Previous screening of about 1,000 equine sera diluted 1:10 selected 72 sera having strong neutralizing activity against Mahoney strain (9) . From the reactivity patterns of these sera in the plaque neutralization test to various PRIgresistant mutants derived from Mahoney strain, five groups of PRIg-containing equine sera represented by HN31, HN11, H33, HS77 and H520 sera were distinguished (9) . Later studies suggested that the latter three were partly related one another in the specificity (10) . Three were substantially similar in the specificity to HN31 serum, 28 to HN11 serum, 31 to either 1133, HS77 or 11520 serum, and the remaining 10 were interpreted as mixtures of several different 64 66
PRIgs (9) . Table I summarizes the reactivity patterns in neutralization reaction of representative animal sera against various PRIg-resistant Mahoney mutants. Similar screening tests on 450 bovine sera have been carried out to date in this laboratory and 84 sera with strong neutralizing activity were selected. Among these, the specificity of selected bovine sera, i.e. BB, B20 and B35, were fully characterized by Hashimoto (11) , who indicated the complex composition of PRIgs contained in these three sera. The results also disclosed the close similarity in neutralization specificity of PRIgs contained in bovine serum B20 and equine serum 1133, in addition to the partial relatedness in specificity between PRIgs contained in bovine serum BB and B20.
In the present study, the remaining 81 bovine sera with strong activity against Mahoney strain were screened for their activity against the mutant Mahoney virus concurrently resistant to five different equine PRIgs (M-HN31-HN11-H33-H520-HS77) and seven sera strongly neutralizing the mutant were obtained. Since these sera were assumed to contain PRIg(s) different in specificity from the previously reported ones, an attempt was made to prepare mutants resistant to each of these bovine sera. It was, however, difficult to prepare mutant viruses against these bovine sera: only one mutant, M-B 1826, was obtained after 10 repeated passages in MS cells in the presence of bovine serum B 1826. Cross neutralization tests using the mutant, M-B 1826, showed that this bovine serum contained a new PRIg different from the known five equine PRIgs (Table I ). The close relationship in neutralization specificity between 1133 and B20 and between HS77 and BB is also shown in the table.
Next, equine and bovine sera were screened for their virus precipitating activity against native antigen of Mahoney virus in agar gel. Thirty-four (4.2%) of 805 equine sera and 6 (3%) of 200 bovine sera examined produced positive precipitations. A clear precipitation line was formed only with equine sera; most bovine sera yielded faint and vague precipitation lines. Therefore, selected virusprecipitating equine sera, inclusive of only two precipitating bovine sera B-1826 and B36, were then analyzed by precipitation reaction. Since precipitating PRIgs in equine sera were identified mainly as IgG(T) globulin (8), these sera were allowed to react in agar gel against various mutant Mahoney strains including M-1133 and M-11T65, which were resistant to PRIgs of an IgG(T) globulin nature. As shown in Table II , two major types of PRIgs differing in the pattern of precipitation reaction were distinguished. One was contained in the two bovine sera, B1826 and M-B36, and precipitated all the mutant Mahoney strains but M-B1826 and M-B36.
The other contained in equine sera showed the same precipitation pattern against were prepared by absorption of anti-Mahoney serum with each of the six mutant Mahoney strains, and their neutralizing titers against Mahoney strain were adjusted to 1:64-128 except for the 11520 antibody. 2The specificity in neutralization reaction of these monospecific antibodies was reported previously (9) . HN3 lab, etc.: HN31 antibody etc.
serum B1826 itself, while the other five antibodies efficiently neutralized M-B1826, indicating that the specificity of B1826 antibody in neutralization reaction is distinct from that of the other five antibodies previously reported (9). The results also disclosed a partial relatedness in specificity between H33 antibody and H577 and 11520 antibodies (10) . The reaction between monospecif is antibodies and PRIg-resistant mutants were then examined by precipitation reaction. Mixtures of anti-Mahoney serum and various mutant Mahoney strains incubated for 1 hr at 37 C and for 3 days at 4
C were subjected to this study. For absorbing antiserum, an antiserum-to-virus ratio of 1:6 was used on the basis of the results from a preliminary experiment.
Absorption experiments with each of the seven mutant viruses including M-B36
revealed that the antisera absorbed with M-HN31, M-HN11 and M-H520 viruses were deficient in virus-precipitating activity against the original as well as mutant Mahoney strains, while H33 and B1826 antibodies corresponding to the virusprecipitating PRIgs, H33 and B1826, precipitated viruses specifically ( Fig. la and  b) . Interestingly, HS77 antibody was also found to be able to react specifically with viruses in spite of the lack of virus-precipitating activity of equine serum HS77 (Fig. lc) . Further, the partial one-way relationship between H33 and HS77 antibodies demonstrated in the neutralization reaction (10) (Table IV) Although H520 antibody did not show any virus-precipitating activity, the fact must be taken with some reservation since the titer of H520 antibody contained in these antisera were invariably low. On the other hand, while PRIgG contained in bovine serum B36 was deficient in virus-neutralizing activity, it showed a prominent activity in precipitation reaction. Antiserum absorption with M-B36 nonreactive to that PRIgG in precipitation reaction, however, removed all the precipitating activity, demonstrating that no antibody with such a mode of action (i.e. virus-precipitating but not neutralizing) and specificity is contained in all the antisera examined.
The origin of PRIgs in animal serum is controversial. Cumulative data, however, seem to indicate two possible mechanisms of production of PRIgs: one is that they are produced in animals by infection with poliovirus itself, and the other is that they are produced against some substances sharing a part of the antigen with poliovirus. Isolation of human enteroviruses from and concomitant antibody response in animals (1,13-15) suggest a part of PRIgs having been produced through the former mechanism, while the finding that PRIgs often tend to neutralize selectively a certain strain of poliovirus within the same type (strain-specific reactivity of PRIgs) seems to favor the latter mechanism. Further, the facts that while PRIg-resistant mutants are selected without difficulty from the parental virus as described in this paper, it is difficult to obtain a mutant virus resistant to polio-antiserum by growing the virus in the presence of the serum (16) and that a new bovine enterovirus partly cross-reactive to human poliovirus type 2 in neutralization reaction was isolated from stools of Indian cattle (17) also favor the latter possibility. In this respect, the results of the present study showing that the majority of equine and at least a part of bovine PRIgs possessed a definite and a similar specificity (H33 or related specificity) are interesting since this might reflect the exposure of these animals to a similar specific antigen.
Recent studies indicate that the composition of the viral antigen and the mechanism of viral neutralization are better understood by the use of homogeneous antibody populations each capable of reacting with a single epitope, i.e. monoclonal antibodies. In this regard, the close relationship between PRIg and monoclonal antibody was demonstrated in our recent study: reactivity of several monoclonal antibodies prepared against Mahoney strain with various PRIgresistant Mahoney strains disclosed that one of the neutralizing monoclonal antibodies, 4C4, possessed the same specificity as HN31 (18); electronmicroscopic studies revealed that the monoclonal antibody 4C4 bound only to the vertices of native and heated poliovirus particles (18) as did the HN31 antibody (19) ; the monoclonal antibody 4C4 failed to precipitate the virus in agar gel (20) as did both the equine serum HN31 and the HN31 antibody. These results also lead us to consider that PRIg is a kind of antibody with a chance reactivity to a definite structure resembling by chance a certain epitope of poliovirus antigen.
